What is he best known for?
The fields of study he is best known for:
His primary areas of investigation include RNA, Genetics, Reverse transcriptase, RNA-dependent RNA polymerase and Molecular biology.
His RNA research includes themes of Genome and Transcription.
Genetics and Computational biology are commonly linked in his work.
His Reverse transcriptase study frequently links to related topics such as Translation.
In his work, genomic DNA, Gene expression and DNA is strongly intertwined with Intron, which is a subfield of RNA-dependent RNA polymerase.
His research in Molecular biology intersects with topics in DNA polymerase, Coding strand, Polymerase and Footprinting.
His most cited work include:
- Identification of the primary site of the human immunodeficiency virus type 1 RNA dimerization in vitro (327 citations)
- Functional Sites in the 5′ Region of Human Immunodeficiency Virus Type 1 RNA Form Defined Structural Domains (250 citations)
- Dimerization of retroviral RNA genomes: an inseparable pair. (249 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of study are RNA, Reverse transcriptase, Molecular biology, Genetics and Transfer RNA.
His studies deal with areas such as Genome and Cell biology as well as RNA.
The Reverse transcriptase study combines topics in areas such as Polymerase, Virology, Retrovirus, Nucleotide and Viral replication.
His Molecular biology study also includes
- DNA which connect with Spermine,
- Stereochemistry most often made with reference to Biochemistry.
His work on Mutant and Mutation as part of his general Genetics study is frequently connected to Dimer, thereby bridging the divide between different branches of science.
As a member of one scientific family, Roland Marquet mostly works in the field of RNA-dependent RNA polymerase, focusing on Non-coding RNA and, on occasion, RNA editing.
He most often published in these fields:
- RNA (58.43%)
- Reverse transcriptase (29.78%)
- Molecular biology (29.21%)
What were the highlights of his more recent work (between 2013-2021)?
- RNA (58.43%)
- Guide RNA (11.24%)
- Cell biology (16.29%)
In recent papers he was focusing on the following fields of study:
Roland Marquet focuses on RNA, Guide RNA, Cell biology, Computational biology and Genome.
His RNA research is included under the broader classification of Genetics.
The concepts of his Cell biology study are interwoven with issues in Translation, Mouse mammary tumor virus, Ubiquitin and Ribonucleoprotein.
As a part of the same scientific family, Roland Marquet mostly works in the field of Computational biology, focusing on Nucleic acid structure and, on occasion, Interference, Capillary electrophoresis and DNA sequencing.
His Genome research incorporates elements of Influenza A virus, Phagocytosis and Viral replication.
His Non-coding RNA research includes elements of RNA editing and RNA-dependent RNA polymerase.
Between 2013 and 2021, his most popular works were:
- Selective packaging of the influenza A genome and consequences for genetic reassortment (95 citations)
- Specific recognition of the HIV-1 genomic RNA by the Gag precursor (66 citations)
- The Life-Cycle of the HIV-1 Gag-RNA Complex. (46 citations)
In his most recent research, the most cited papers focused on:
His primary scientific interests are in RNA, Guide RNA, Genome, Genetics and Virology.
His work on RNA is being expanded to include thematically relevant topics such as Influenza A virus.
His studies link Binding selectivity with Genetics.
His study in Virology is interdisciplinary in nature, drawing from both Plasma protein binding and Ubiquitin.
His Viral life cycle research is multidisciplinary, incorporating perspectives in Translation, Retrovirus, Transcription and Function.
His work deals with themes such as RNA-dependent RNA polymerase, Small nuclear RNA, Reverse transcriptase, Internal loop and Viral rna, which intersect with Molecular biology.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
